Tolvaptan, an Oral Vasopressin Antagonist, in Treatment of Hyponatremia in Cirrhosis
Article Sidebar
Published:
Dec 20, 2024
Keywords:
Hyponatremia, Cirrhosis, Tolvaptan, Vasopressin Antagonist
Main Article Content
Abstract
Tolvaptan is a vasopressin V2- receptorv antagonist that improves serum sodium concerntration by increasing renal solute- free water excretion.
Article Details
How to Cite
Jayaswal, M., Kumar, V., & Agarwal, A. K. (2024). Tolvaptan, an Oral Vasopressin Antagonist, in Treatment of Hyponatremia in Cirrhosis. Patna Journal of Medicine, 98(1), 38–43. Retrieved from https://9vom.in/journals/index.php/pjm/article/view/430
Section
Original Research
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.